Steven Ahrendt, MD
Professor, Surgery-Surgical Oncology

Photo
Download CV
Medical School:
  • MD, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (1987)
Undergraduate School:
  • BS, University of Illinois–Urbana-Champaign (IL) (1983)
Internship:
  • Johns Hopkins University School of Medicine Program (1988)
Residency:
  • Johns Hopkins University School of Medicine Program, Chief Resident, Surgery (1994)
Fellowships:
  • Johns Hopkins University School of Medicine Program, Complex General Surgical Oncology (1995)
Languages: English, German
Department: Surgery-Surgical Oncology

Professional Titles

  • Professor, Surgery-Surgical Oncology
  • Director, Cytoreductive Surgery/HIPEC Program

Teaching

  • Visiting Professor (2017)
    School of Medicine, Surgery

Publications

  • Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL. Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei. Ann Surg Oncol. 2018 Jan;25(1):76-82. PubMed PMID: 29110275
  • Choudry MHA, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL. Postoperative Complications Independently Predict Cancer-Related Survival in Peritoneal Malignancies. Ann Surg Oncol. 2018 Dec;25(13):3950-3959. PubMed PMID: 30302637
  • Amblard I, Mercier F, Bartlett DL, Ahrendt SA, Lee KW, Zeh HJ, Levine EA, Baratti D, Deraco M, Piso P, Morris DL, Rau B, Tentes AAK, Tuech JJ, Quenet F, Akaishi E, Pocard M, Yonemura Y, Lorimier G, Delroeux D, Villeneuve L, Glehen O, Passot G. Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups. Eur J Surg Oncol. 2018 Sep;44(9):1378-1383. PubMed PMID: 30131104
  • Torphy RJ, Friedman C, Halpern A, Chapman BC, Ahrendt SS, McCarter MM, Edil BH, Schulick RD, Gleisner A. Comparing Short-term and Oncologic Outcomes of Minimally Invasive Versus Open Pancreaticoduodenectomy Across Low and High Volume Centers. Ann Surg. 2018 May 16. [Epub ahead of print] PubMed PMID: 29771723
  • Low CA, Bovbjerg DH, Ahrendt S, Choudry MH, Holtzman M, Jones HL, Pingpank JF Jr, Ramalingam L, Zeh HJ 3rd, Zureikat AH, Bartlett DL. Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission. Ann Behav Med. 2018 Jan 5;52(1):88-92. PubMed PMID: 29538623
  • Choudry HA, Pai RK, Shuai Y, Ramalingam L, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL. Impact of Cellularity on Oncologic Outcomes Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Pseudomyxoma Peritonei. Ann Surg Oncol. 2018 Jan;25(1):76-82. PubMed PMID: 29110275
  • Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE. Ann Surg Oncol. 2018 Jun;25(6):1668-1675. PubMed PMID: 29637438
  • Mercier F, Bakrin N, Bartlett DL, Goere D, Quenet F, Dumont F, Heyd B, Abboud K, Marolho C, Villeneuve L, Glehen O. Peritoneal Carcinomatosis of Rare Ovarian Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Multi-Institutional Cohort from PSOGI and BIG-RENAPE. Ann Surg Oncol. 2018 Jun;25(6):1668-1675. PubMed PMID: 29637438
  • Pakraftar S, Ramalingam L, Shuai Y, Jones HL, Pingpank JF, Ahrendt SS, Holtzman MP, Zureikat AH, Zeh HJ, Bartlett DL, Choudry HA. Institutional Experience with Ostomies Created During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion. Ann Surg Oncol. 2017 Dec;24(13):3811-3817. PubMed PMID: 29019111
  • Magge D, Ramalingam L, Shuai Y, Edwards RP, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL, Choudry HA. Hyperthermic intraperitoneal chemoperfusion as a component of multimodality therapy for ovarian and primary peritoneal cancer. J Surg Oncol. 2017 Sep;116(3):320-328. PubMed PMID: 28628712
  • Dhir M, Choudry HA, Holtzman MP, Pingpank JF, Ahrendt SA, Zureikat AH, Hogg ME, Bartlett DL, Zeh HJ, Singhi AD, Bahary N. Impact of genomic profiling on the treatment and outcomes of patients with advanced gastrointestinal malignancies. Cancer Med. 2017 Jan;6(1):195-206. PubMed PMID: 28028924
  • Dhir M, Ramalingam L, Shuai Y, Pakrafter S, Jones HL, Hogg ME, Zureikat AH, Holtzman MP, Ahrendt SA, Bahary N, Pingpank JF, Zeh HJ, Bartlett DL, Choudry HA. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal Metastases. Ann Surg Oncol. 2017 Apr;24(4):875-883. PubMed PMID: 27995449
  • Kermanshahi TR, Magge D, Choudry H, Ramalingam L, Zhu B, Pingpank J, Ahrendt S, Holtzman M, Zeh H, Bartlett D, Zureikat A, Pai RK. Mucinous and Signet Ring Cell Differentiation Affect Patterns of Metastasis in Colorectal Carcinoma and Influence Survival. Int J Surg Pathol. 2017 Apr;25(2):108-117. PubMed PMID: 27571790
View All (13 Total) View Less

Professional Memberships

  • American College of Surgeons, Fellow
  • Society of Surgical Oncology, Member

Practice Locations

UCH - Cancer Center
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

CU Specialty Care at Highlands Ranch Cancer Care - Surgical Oncology
1500 Park Central Drive, Suite 101
Highlands Ranch, CO 80129
720-516-1092

Hospital Affiliation
  • University of Colorado Hospital
Center Affiliations

Specialty Information

Specialties
  • Surgery, Board Certification (1995, 2015)
  • Advanced Specialty Training in Surgical Oncology, Certificate (1995)
Conditions & Treatments
  • Cancers - Cancer Surgery
  • Cancers
  • Cancers - Colorectal Cancer
  • Cancers - Gastroenterologic Cancer (Colon, Stomach, Esophageal, Liver)
  • Cancers - Ovarian Cancer
  • Cancers - Pancreatic Cancer
  • Cancers - Sarcoma
Clinical Interests
My clinical interests include the treatment of patients with abdominal cancer including the care of patients with appendiceal, colon, and ovarian cancer, malignant mesothelioma, pseudomyxoma peritonei, and other abdominal malignancies with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Care Philosophy
My goal is to provide personalized compassionate surgical care to every patient. I also strive to guide and support my patients through their multidisciplinary cancer treatment and survivorship.

Public Speaking
Yes

General Information

Medical Schools:
  • MD, University of Chicago Division of the Biological Sciences The Pritzker School of Medicine (1987)
Undergraduate Schools:
  • BS, University of Illinois–Urbana-Champaign (IL) (1983)
Internships:
  • Johns Hopkins University School of Medicine Program (1988)
Residency Programs:
  • Johns Hopkins University School of Medicine Program, Chief Resident, Surgery (1994)
Fellowships:
  • Johns Hopkins University School of Medicine Program, Complex General Surgical Oncology (1995)
Download CV
Languages: English, German
Department: Surgery-Surgical Oncology
;